Source:  GrowBLOX Sciences, Inc. Press Release, June 3 2014

LAS VEGAS, June 2, 2014 /PRNewswire/ — GrowBLOX Sciences, Inc. (OTCQB: GBLX), a biotechnology and research company, today announced it has been added to the Marijuana Index (MJX).  The Marijuana index is the only registered equity tracking index that features publicly traded companies involved in the marijuana sector, providing the most up-to-date and robust information in the industry.

GrowBLOX Sciences CEO, Craig Ellins said, “we are delighted to be added to the Marijuana Index.  It is the first equity tracking index of its kind that allows investors an in depth look at the myriad of cannabis companies and the great work they are achieving.”

The index’s website states: “The Marijuana Index is the first and only registered equity tracking index which monitors the performance, news and general pulse of qualified marijuana stocks or cannabis stocks. Weighted by market capitalization (as determined by common shares outstanding multiplied by last trade price), the index provides existing or prospective investors with a narrow and centralized view of these pioneering securities which are positioned in a multibillion dollar growth industry.”

About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation.  The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product.  The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions.

Forward-Looking Statements
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are inherently unreliable and actual results may differ materially.  Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results.  Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company’s ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Craig Ellins
CEO, GrowBLOX Sciences, Inc.
+1-844-843-BLOX ext. 01

SOURCE GrowBLOX Sciences, Inc.

Source: PR Newswire (June 2, 2014 – 4:10 PM EDT)